نتایج جستجو برای: α synuclein

تعداد نتایج: 167644  

2017
GABRIEL GUSTAFSSON Marina Romero-Ramos

Gustafsson, G. 2017. Alpha-Synuclein Oligomers. Cellular Mechanisms and Aspects of Antibody Treatment. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1344. 64 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0008-5. In Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), aggregated α-synuclein deposit inside cells within the brain. Sma...

2015
Asuka Sasaki Shigeki Arawaka Hiroyasu Sato Takeo Kato

α-Synuclein deposited in Lewy bodies, a pathological hallmark of Parkinson's disease (PD), is highly phosphorylated at serine 129 (Ser129). In contrast, there is very little Ser129-phosphorylated α-synuclein in the normal brains. This difference suggests that Ser129-phosphorylation is involved in neurodegenerative processes of PD. However, the role of this modification remains unclear. One limi...

2014
Gabor Kovacs

α-synuclein pathology presenting as tiny dots, thin neurites, and larger amorphous deposits in the subependymal area, as well as tiny dots between ependymal cells in the brains of individuals with neuropathologically proven Parkinson`s disease (Braak stages 5 and 6). Immunostaining was performed using antibody 5G4 (Roboscreen, Leipzig, Germany; we applied 1 : 2,000 dilution and a pretreatment o...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2012
Ana Clara Cristóvão Subhrangshu Guhathakurta Eugene Bok Goun Je Seung Don Yoo Dong-Hee Choi Yoon-Seong Kim

Accumulation of misfolded α-synuclein is the pathological hallmark of Parkinson's disease (PD). Nevertheless, little is known about the mechanism contributing to α-synuclein aggregation and its further toxicity to dopaminergic neurons. Since oxidative stress can increase the expression and aggregation levels of α-synuclein, NADPH oxidases (Noxs), which are responsible for reactive oxygen specie...

2011
Michael Fiske Stephanie Valtierra Keith Solvang Michael Zorniak Michael White Sara Herrera Alina Konnikova Rebecca Brezinsky Shubhik DebBurman

In Parkinson's disease (PD), misfolded and aggregated α-synuclein protein accumulates in degenerating midbrain dopaminergic neurons. The amino acid alanine-76 in α-synuclein and phosphorylation at serine-87 and serine-129 are thought to regulate its aggregation and toxicity. However, their exact contributions to α-synuclein membrane association are less clear. We found that α-synuclein is indee...

2014
Jane R. Allison Robert C. Rivers John C. Christodoulou Michele Vendruscolo Christopher M. Dobson

α-Synuclein is an intrinsically disordered protein whose aggregation is implicated in Parkinson's disease. A second member of the synuclein family, β-synuclein, shares significant sequence similarity with α-synuclein but is much more resistant to aggregation. β-Synuclein is missing an 11-residue stretch in the central non-β-amyloid component region that forms the core of α-synuclein amyloid fib...

2016
Ariadna Recasens Celine Perier Carolyn M. Sue

Growing evidence suggests that increased levels of α-synuclein might contribute to the pathogenesis of Parkinson's disease (PD) and therefore, it is crucial to understand the mechanisms underlying α-synuclein expression. Recently, microRNAs (miRNAs) have emerged as key regulators of gene expression involved in several diseases such as PD and other neurodegenerative disorders. A systematic liter...

2013
Theodore A. Sarafian Christopher M. Ryan Puneet Souda Eliezer Masliah Upendra K. Kar Harry V. Vinters Gary W. Mathern Kym F. Faull Julian P. Whitelegge Joseph B. Watson

While most forms of Parkinson's Disease (PD) are sporadic in nature, a small percentage of PD have genetic causes as first described for dominant, single base pair changes as well as duplication and triplication in the α-synuclein gene. The α-synuclein gene encodes a 140 amino acid residue protein that interacts with a variety of organelles including synaptic vesicles, lysosomes, endoplasmic re...

2013
Shyra J. Gardai Wenxian Mao Birgitt Schüle Michael Babcock Sue Schoebel Carlos Lorenzana Jeff Alexander Sam Kim Heather Glick Kathryn Hilton J. Kent Fitzgerald Manuel Buttini San-San Chiou Lisa McConlogue John P. Anderson Dale B. Schenk Frederique Bard J. William Langston Ted Yednock Jennifer A. Johnston

Alpha-synuclein protein is strongly implicated in the pathogenesis Parkinson's disease. Increased expression of α-synuclein due to genetic multiplication or point mutations leads to early onset disease. While α-synuclein is known to modulate membrane vesicle dynamics, it is not clear if this activity is involved in the pathogenic process or if measurable physiological effects of α-synuclein ove...

Journal: :Molecular therapy : the journal of the American Society of Gene Therapy 2017
Kirsty J McMillan Tracey K Murray Nora Bengoa-Vergniory Oscar Cordero-Llana Jane Cooper Amy Buckley Richard Wade-Martins James B Uney Michael J O'Neill Liang F Wong Maeve A Caldwell

Abnormal alpha-synuclein (α-synuclein) expression and aggregation is a key characteristic of Parkinson's disease (PD). However, the exact mechanism(s) linking α-synuclein to the other central feature of PD, dopaminergic neuron loss, remains unclear. Therefore, improved cell and in vivo models are needed to investigate the role of α-synuclein in dopaminergic neuron loss. MicroRNA-7 (miR-7) regul...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید